Facet Wealth Inc. Has $499,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Facet Wealth Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 953 shares of the healthcare conglomerate’s stock after selling 594 shares during the period. Facet Wealth Inc.’s holdings in UnitedHealth Group were worth $499,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter valued at $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter valued at about $30,000. Kapitalo Investimentos Ltda bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $41,000. Finally, Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $42,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on UNH shares. Piper Sandler lowered their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday, June 3rd. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Saturday, May 24th. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. Barclays restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research note on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $392.29.

Insider Transactions at UnitedHealth Group

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the purchase, the chief executive officer directly owned 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director owned 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Trading Up 0.8%

Shares of NYSE UNH opened at $280.69 on Monday. The company’s 50 day simple moving average is $301.58 and its 200 day simple moving average is $424.22. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The firm has a market capitalization of $254.62 billion, a P/E ratio of 11.75, a P/E/G ratio of 1.39 and a beta of 0.45.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.15%. UnitedHealth Group’s payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.